Skip to main content

The porphyria therapies market is projected to grow at an annualized rate of 10.97% during the period 2021-2030, claims Roots Analysis

 

Roots Analysis has announced the addition of “Porphyria Targeting Therapies Market” report to its list of offerings.

 

Porphyria is a rare disorder that is characterized by excessive accumulation of porphyrin, a compound that aids in the formation of heme (an essential part of hemoglobin that helps carry oxygen in blood). Any anomaly caused by genetic or acquired abnormalities in heme biosynthesis (produced majorly in bone marrow and liver) can result in toxicity. It is worth highlighting that, till date, more than 1,000 mutations that can cause porphyria have been identified. However, prevalence of porphyria still remains unknown. Several treatment options such as gene therapy, proteasome inhibition and pharmacologic chaperones are currently being investigated among various other targeted treatment options.

 

To order this 130+ slides report, which features 90+ figures, please visit https://www.rootsanalysis.com/reports/porphyria-pipline-review.html.

 

Key Market Insights

 

15+ therapies have been / are being developed for the different type of porphyria

Treatment.

More than 70% of the aforementioned candidates are currently under clinical evaluation. Further, three therapies, namely Panhematin™, GIVLAARI® and SCENESSE®, have already been approved for the treatment of different types of porphyria.

 

Around 50% of the therapeutics are being developed as biologics

Majority (over 65%) of the abovementioned biologic drugs have been / are being designed for administration via the intravenous route. Furthermore, majority of the drugs (37%) have been / are being targeting acute intermittent porphyria.

 

Over 30% of the therapies have been / are being developed for erythropoietic protoporphyria

More than 65% the abovementioned therapies are currently being evaluated in clinical phases. Further, around 60% of the aforementioned therapy candidates are being developed as small molecules.

 

To request a sample copy / brochure of this report, please visit this https://www.rootsanalysis.com/reports/porphyria-pipline-review/request-sample.html

 

Key Questions Answered

§  What are the prevalent R&D trends related to Porphyria?

§  What are the key challenges faced by stakeholders engaged in this domain?

§  What are the principal therapies developed by the companies in this domain?

§  Who are the leading industry and non-industry players in this market?

§  What are the key geographies where research on porphyria is actively being conducted?

§  Who are the key investors in this domain?

§  Who are the key opinion leaders / experts in this field?

§  What kind of partnership models are commonly adopted by industry stakeholders?

§  What are the factors that are likely to influence the evolution of this upcoming market?

§  How is the current and future market opportunity likely to be distributed across key market segments?

 

For additional details, please visit https://www.rootsanalysis.com/reports/porphyria-pipline-review.html or email sales@rootsanalysis.com

 

You may also be interested in the following titles:

1.       Progressive Supranuclear Palsy: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2030

2.       Soft Tissue Sarcoma: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2030

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 

Contact Information

Roots Analysis Private Limited

Ben Johnson

+1 (415) 800 3415

ben.johnson@rootsanalysis.com

Comments

Post a Comment

Popular posts from this blog

NOVEL DRUG RECONSTITUTION SYSTEMS - CURRENT MARKET LANDSCAPE

  Over the years, novel drug reconstitution systems have been widely adopted in the healthcare sector, owing to the numerous benefits offered by these products. During our research, we identified over 55 novel drug reconstitution systems , including prefilled syringes, cartridges and infusion bags being manufactured to ease the reconstitution of drugs packaged in containers. To order this detailed 180+ page report, please visit this - https://www.rootsanalysis.com/reports/drug-reconstitution-systems-market.html     Majority of the companies (32%) engaged in this domain are very large players. Examples of such companies include ( in alphabetical order, established after 1900 ) Baxter, Fresenius Kabi, ICU Medical, Shandong Pharmaceutical Glass, Terumo, Vetter Pharma and West Pharmaceutical Services. This is followed by the share of mid-sized players (29%) in this domain. P rominent examples of mid-sized players include ( in alphabetical order, established after...
Post a Comment
Read more

Manufacturing Market Continuous by Roots Analysis

    Recent advances in the manufacturing technologies have prompted pharmaceutical companies to consider shifting from the traditional multi-step, batch manufacturing processes to faster, and relatively more efficient continuous manufacturing   Roots Analysis is pleased to announce the publication of its recent study, titled, “ Manufacturing Market Continuous (Small Molecules and Biologics), 2020 – 2030 .”   The report features an extensive study of the current market landscape and future opportunities for companies with capabilities in continuous manufacturing (both innovator companies with in-house expertise and contract manufacturers). It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes: §   A detailed assessment of the overall landscape of companies with capabilities for continuous manufacturing §   Elaborate profiles of some o...
Post a Comment
Read more

Digital Health Market: Focus on Digital Therapeutics by Roots Analysis

  Recent advances in information technology and biomedical science have enabled the development of a number of versatile digital solutions that are capable of either mimicking or augmenting, the fundamental qualities of pharmacological interventions   Roots Analysis has announced the addition of “ Digital Health Market: Focus on Digital Therapeutics (2nd Edition), 2020-2030 (Based on Type of Solution (Software Solution, Gaming Solution and Combination Solution), Type of Therapy (Curative and Preventive), and Purpose of Solution (Medication Replacement and Medication Augmentation” report to its list of offerings.   According to experts, digital therapeutic solutions are primarily based on behavior modification and are designed to address a variety of therapeutic needs across a wide range of disease indications. On the other hand, several digital solutions have been developed to enable remote doctor-patient consultations. Such solutions witnessed a surge in ado...
Post a Comment
Read more